 July 22, 2021 Breda, the Netherlands argenx Euronext Nasdaq: ARGX, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that it will host a conference call and audio webcast on Thursday, July 29, 2021 at 2:30 p.m. CET 8:30 a.m. ET to discuss its half year 2021 financial results and provide a second quarter business update. 